An Investigation into the effect of Clozapine treatment on the level of serum immunoglobulins

Trial Profile

An Investigation into the effect of Clozapine treatment on the level of serum immunoglobulins

Recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs Clozapine (Primary)
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Feb 2016 Planned End Date changed from 31 Dec 2015 to 31 Oct 2016 as reported by United Kingdom Clinical Research Network record.
    • 20 Feb 2016 Accrual to date is 61% according to United Kingdom Clinical Research Network record.
    • 17 Dec 2015 Accrual to date is 58% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top